AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / HOSPITAL & MEDICAL SERVICE PLANS
Clover Health Investments, Corp
XNAS · usd
SIC 6324 · HOSPITAL & MEDICAL SERVICE PLANS
FIGI BBG00SHY90K3
4.60▼ 0.13 (-2.75%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
4.73
Day's Range
4.53 – 4.72
52-Week Range
1.58 – 5.59
Volume
3.1M
Avg Volume
4.3M
Share Statistics
Shares Outstanding
Employees
724
Exchange
XNAS
Listed
2021-01-08
Share count as of July 31, 2026

Clover Health Investments, Corp (CLOV) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Clover Health Investments, Corp (CLOV)
What is Clover Health Investments, Corp's Market Cap?
Clover Health Investments, Corp's Market Cap is $2.4B, based on as-reported figures from SEC (XBRL) filings.
What is Clover Health Investments, Corp's Price / Sales?
Clover Health Investments, Corp's Price / Sales is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Clover Health Investments, Corp's Revenue (TTM)?
Clover Health Investments, Corp's Revenue (TTM) is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is Clover Health Investments, Corp's Net Income (TTM)?
Clover Health Investments, Corp's Net Income (TTM) is -$18.4M, based on as-reported figures from SEC (XBRL) filings.
What is Clover Health Investments, Corp's EBITDA?
Clover Health Investments, Corp's EBITDA is -$16.5M, based on as-reported figures from SEC (XBRL) filings.
What is Clover Health Investments, Corp's Diluted EPS (TTM)?
Clover Health Investments, Corp's Diluted EPS (TTM) is -0.03, based on as-reported figures from SEC (XBRL) filings.
What is Clover Health Investments, Corp's EBITDA Margin?
Clover Health Investments, Corp's EBITDA Margin is -0.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CLOVAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Premiums earned, net (Net of ceded premiums of $91 and $96 for the three months ended June 30, 2026 and 2025 respectively, and $183 and $192 for the six months ended June 30, 2026 and 2025, respectively)
Other income
Total revenues
YoY growth+60.7%+44.7%+50.1%
Operating expenses:
Net medical claims incurred
Salaries and benefits
General and administrative expenses
Depreciation and amortization
Total operating expenses
% of revenue96.2%110.1%104.9%
Income (loss) from operations
% of revenue3.8%-10.1%-4.9%
Change in fair value of warrants
Net income (loss)——
% of revenue3.8%——
Basic earnings (loss) per share (in dollars per share)—
Diluted earnings (loss) per share (in dollars per share)—